- Home
- FDBC vs AMRN Comparison
FDBC vs AMRN Comparison
Compare FDBC & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDBC | AMRN |
|---|---|---|
| Founded | 1902 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 309.4M | 287.9M |
| IPO Year | 2000 | 1998 |
Fundamental Metrics
Financial Performance| Metric | FDBC | AMRN |
|---|---|---|
| Price | $54.60 | $13.44 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 5.8K | ★ 79.0K |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | 35.00 | ★ 55.00 |
| EPS | ★ 2.63 | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | $20.99 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $39.87 | $12.96 |
| 52 Week High | $56.90 | $20.90 |
Technical Indicators
Market Signals| Indicator | FDBC | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 38.27 |
| Support Level | $52.79 | N/A |
| Resistance Level | $56.14 | $14.50 |
| Average True Range (ATR) | 1.23 | 0.39 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 31.27 | 19.09 |
Price Performance
Historical ComparisonAbout FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), the company provides a full range of banking, trust and financial services to individuals, small businesses and corporate customers. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. The company's segments include: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate, with the majority of revenue generating from the Commercial Real Estate segment.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.